Solid Biosciences Inc. SLDB Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s other working capital?
- Solid Biosciences Inc. (SLDB) reported other working capital of $0 in Q1 2026.
- How has Solid Biosciences Inc.'s other working capital changed year-over-year?
- Solid Biosciences Inc.'s other working capital decreased by 100.0% year-over-year, from $22K to $0.
- What is the long-term trend for Solid Biosciences Inc.'s other working capital?
- Over 2 years (2023 to 2025), Solid Biosciences Inc.'s other working capital has grown at a -20.1% compound annual growth rate (CAGR), from -$374K to $239K.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.